Single-Cell Genomics Could Improve IVF Screening
By Susan Young,
MIT Technology Review
| 11. 05. 2013
Fertility doctors in Beijing have begun testing a new method for genome analysis of human eggs before using them for in vitro fertilization or IVF. The tests, using technology developed by a Harvard chemist, allow doctors to know the genome of a woman’s egg before it is used in IVF, which could provide a safer way to help their patients avoid genetic disorders in children.
The test is part of a larger effort by researchers to develop techniques to sequence the genomes of single cells. In some medical situations, such as when examining the scarce cancer cells that can be found in some patients’ blood (see “
Finding Cancer Cells in the Blood”), doctors have only a tiny amount of genetic material to work with and so must use specialized techniques to prepare samples for DNA sequencing.
Researchers are also exploring single-cell-genomics techniques as part of screening tests in fertility clinics. Genetic analyses that are more limited than whole-genome sequencing are already widely performed on IVF embryos by plucking a single cell from an embryo to determine the...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...